Earnings Feed
Start Free
Liberty Latin America Ltd.·4

Jul 17, 8:14 PM ET

NOYES CHRISTOPHER J 4

4 · Liberty Latin America Ltd. · Filed Jul 17, 2026

Research Summary

AI-generated summary of this filing

Updated

Liberty Latin America CFO Christopher Noyes Receives Preferred Shares

What Happened

  • Christopher J. Noyes, Chief Financial Officer of Liberty Latin America (LILA), reported receiving 88,634 newly issued 9.0% Series A Preferred Shares as a special dividend payable June 16, 2026. The preferred shares have an initial liquidation price of $25 each (≈ $2.22M liquidation value).
  • The Form 4 also shows additional non-cash adjustments recorded June 16–17, 2026: 4,075 RSU-type rights/awards and three derivative (SAR) adjustments of 7,873, 14,953 and 19,354 shares. All these were recorded at $0.00 because they reflect the dividend and related anti-dilution adjustments to awards, not open-market purchases.

Key Details

  • Transaction dates: June 16, 2026 (preferred shares and RSU adjustments) and June 17, 2026 (derivative/SAR adjustments). Form filed July 17, 2026.
  • Reported prices: $0.00 for all entries (non-cash dividend/award adjustments). Preferred shares have $25 liquidation price for valuation context.
  • Notable footnotes: Issuer declared a special dividend on May 21, 2026 (0.10 Series A Preferred per outstanding common share). SAR and RSU awards were adjusted under anti-dilution provisions and approved by the compensation committee pursuant to Rule 16b-3.
  • Vesting/derivative notes: Some adjusted SARs/RSUs have standard vesting schedules (various footnotes reference vesting in 2027–2029); at least one derivative security is noted as fully vested.
  • Filing timeliness: The Form 4 reports transactions on June 16–17 but was filed July 17, 2026 — this appears late relative to the 2-business-day Form 4 filing requirement.

Context

  • These entries reflect a non-cash corporate action (special dividend in preferred shares) and corresponding anti-dilution adjustments to equity awards (SARs/RSUs). They are not open-market buys or sales and do not on their own indicate a trading decision by the insider.

Insider Transaction Report

Form 4
Period: 2026-06-16
Liberty Latin America Ltd.LILA
NOYES CHRISTOPHER J
SVP, CHIEF FINANCIAL OFFICER
Transactions
  • Other

    Series A Preference Shares

    [F1]
    2026-06-16+88,634→ 88,634 total
  • Other

    Series A Preference Shares

    [F1]
    2026-06-16+4,075→ 4,075 total(indirect: By IRA)
  • Other

    Restricted Share Units P

    [F2][F3][F4]
    2026-06-17+7,873→ 7,873 total
    → Series A Preference Shares (7,873 underlying)
  • Other

    Restricted Share Units P

    [F2][F3][F5]
    2026-06-17+14,953→ 14,953 total
    → Series A Preference Shares (14,953 underlying)
  • Other

    Restricted Share Units P

    [F2][F3][F6]
    2026-06-17+19,354→ 19,354 total
    → Series A Preference Shares (19,354 underlying)
Holdings

  • Share Appreciation Rights A

    [F7][F8]
    Exercise: $15.10Exp: 2028-01-02→ Class A Common Shares (16,951 underlying)
    16,951

  • Share Appreciation Rights C

    [F7][F9]
    Exercise: $14.56Exp: 2028-01-02→ Class C Common Shares (34,850 underlying)
    34,850

  • Share Appreciation Rights A

    [F7][F10]
    Exercise: $13.03Exp: 2028-05-01→ Class A Common Shares (41,377 underlying)
    41,377

  • Share Appreciation Rights C

    [F7][F11]
    Exercise: $12.41Exp: 2028-05-01→ Class C Common Shares (85,068 underlying)
    85,068

  • Share Appreciation Rights A

    [F7][F12]
    Exercise: $13.93Exp: 2029-05-01→ Class A Common Shares (40,533 underlying)
    40,533

  • Share Appreciation Rights C

    [F7][F13]
    Exercise: $13.63Exp: 2029-05-01→ Class C Common Shares (83,334 underlying)
    83,334

  • Share Appreciation Rights A

    [F7][F14]
    Exercise: $7.29Exp: 2030-03-16→ Class A Common Shares (72,842 underlying)
    72,842

  • Share Appreciation Rights C

    [F7][F15]
    Exercise: $7.13Exp: 2030-03-16→ Class C Common Shares (149,760 underlying)
    149,760

  • Share Appreciation Rights A

    [F7][F16]
    Exercise: $9.80Exp: 2031-03-16→ Class A Common Shares (143,000 underlying)
    143,000

  • Share Appreciation Rights C

    [F7][F17]
    Exercise: $9.60Exp: 2031-03-16→ Class C Common Shares (294,000 underlying)
    294,000

  • Share Appreciation Rights A

    [F7][F18]
    Exercise: $9.80Exp: 2031-03-16→ Class A Common Shares (107,723 underlying)
    107,723

  • Share Appreciation Rights C

    [F7][F19]
    Exercise: $9.60Exp: 2031-03-16→ Class C Common Shares (221,473 underlying)
    221,473

  • Share Appreciation Rights A

    [F7][F20]
    Exercise: $6.78Exp: 2032-03-11→ Class A Common Shares (165,393 underlying)
    165,393

  • Share Appreciation Rights C

    [F7][F21]
    Exercise: $6.56Exp: 2032-03-11→ Class C Common Shares (340,040 underlying)
    340,040

  • Share Appreciation Rights A

    [F7][F22]
    Exercise: $5.47Exp: 2033-03-20→ Class A Common Shares (171,833 underlying)
    171,833

  • Share Appreciation Rights C

    [F7][F23]
    Exercise: $5.30Exp: 2033-03-20→ Class C Common Shares (353,279 underlying)
    353,279

  • Share Appreciation Rights A

    [F24][F25]
    Exercise: $4.31Exp: 2034-03-12→ Class A Common Shares (213,114 underlying)
    213,114

  • Share Appreciation Rights C

    [F24][F26]
    Exercise: $4.24Exp: 2034-03-12→ Class C Common Shares (438,151 underlying)
    438,151

  • Share Appreciation Rights A

    [F27][F28]
    Exercise: $4.68Exp: 2035-03-14→ Class A Common Shares (196,969 underlying)
    196,969

  • Share Appreciation Rights C

    [F27][F29]
    Exercise: $4.54Exp: 2035-03-14→ Class C Common Shares (404,958 underlying)
    404,958

  • Share Appreciation Rights A

    [F30][F31]
    Exercise: $5.31Exp: 2036-03-13→ Class A Common Shares (174,389 underlying)
    174,389

  • Share Appreciation Rights C

    [F30][F32]
    Exercise: $5.29Exp: 2036-03-13→ Class C Common Shares (358,535 underlying)
    358,535
Footnotes (32)
  • [F1]On May 21, 2026, the Issuer announced that an authorized committee of the Issuer's board of directors declared a special dividend on each of its outstanding common shares payable on June 16, 2026 to all holders of record as of 5:00 p.m., New York City time, on June 1, 2026 consisting of a special dividend of 0.10 shares of newly issued 9.0% Fixed Rate Cumulative Perpetual Redeemable Series A Preferred Shares (the "Preferred Shares"), having an initial liquidation price of $25 per Preferred Share (the "Dividend"). As a result of the Dividend, the reporting person directly received 88,634 Preferred Shares.
  • [F10]This share appreciation right award ("SAR") was previously reported as a SAR relating to 28,935 shares of the Issuer's common stock at a base price of $18.63 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  • [F11]This SAR was previously reported as a SAR relating to 57,870 shares of the Issuer's common stock at a base price of $18.24 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  • [F12]This SAR was previously reported as a SAR relating to 28,345 shares of the Issuer's common stock at a base price of $19.91 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  • [F13]This SAR was previously reported as a SAR relating to 56,690 shares of the Issuer's common stock at a base price of $20.03 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  • [F14]This SAR was previously reported as a SAR relating to 50,939 shares of the Issuer's common stock at a base price of $10.42 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  • [F15]This SAR was previously reported as a SAR relating to 101,878 shares of the Issuer's common stock at a base price of $10.48 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  • [F16]This SAR was previously reported as a SAR relating to 100,000 shares of the Issuer's common stock at a base price of $14.00 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  • [F17]This SAR was previously reported as a SAR relating to 200,000 shares of the Issuer's common stock at a base price of $14.10 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  • [F18]This SAR was previously reported as a SAR relating to 75,331 shares of the Issuer's common stock at a base price of $14.00 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  • [F19]This SAR was previously reported as a SAR relating to 150,662 shares of the Issuer's common stock at a base price of $14.10 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  • [F2]Each Restricted Share Unit P ("RSU") represents a right to receive one share of the Issuer's Series A Preference Shares at settlement.
  • [F20]This SAR was previously reported as a SAR relating to 115,660 shares of the Issuer's common stock at a base price of $9.69 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  • [F21]This SAR was previously reported as a SAR relating to 231,320 shares of the Issuer's common stock at a base price of $9.63 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  • [F22]This SAR was previously reported as a SAR relating to 120,163 shares of the Issuer's common stock at a base price of $7.81 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  • [F23]This SAR was previously reported as a SAR relating to 240,326 shares of the Issuer's common stock at a base price of $7.78 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  • [F24]The SARs vest fully on March 15 2027.
  • [F25]This SAR was previously reported as a SAR relating to 149,031 shares of the Issuer's common stock at a base price of $6.16 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  • [F26]This SAR was previously reported as a SAR relating to 298,062 shares of the Issuer's common stock at a base price of $6.22 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  • [F27]The Share Appreciation Rights vest in two equal annual installments commencing on March 15 2027 and 2028.
  • [F28]This SAR was previously reported as a SAR relating to 137,741 shares of the Issuer's common stock at a base price of $6.69 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  • [F29]This SAR was previously reported as a SAR relating to 275,482 shares of the Issuer's common stock at a base price of $6.66 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  • [F3]In connection with the Dividend, all RSUs with respect to the Issuer's common stock ("Original RSUs") were adjusted pursuant to the anti-dilution provisions of the incentive plans under which the RSU awards held by the reporting person were granted. Each holder of an Original RSU was entitled to receive an RSU with respect to a number of Preferred Shares equal to 0.10 multiplied by the number of shares of common stock underlying the Original RSU, subject to the same terms and conditions as the Original RSU. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  • [F30]The Share Appreciation Rights vest in three equal annual installments on March 15 of 2027, 2028 and 2029.
  • [F31]This SAR was previously reported as a SAR relating to 121,951 shares of the Issuer's common stock at a base price of $7.58 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  • [F32]This SAR was previously reported as a SAR relating to 243,902 shares of the Issuer's common stock at a base price of $7.77 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  • [F4]The Restricted Share Units vest in full on March 15, 2027.
  • [F5]The RSUs vest in two equal annual installments on March 15 of 2027 and 2028.
  • [F6]The RSUs vest in three equal annual installments on March 15 of 2027, 2028 and 2029.
  • [F7]The derivative security is fully vested.
  • [F8]This SAR was previously reported as a SAR relating to 11,854 shares of the Issuer's common stock at a base price of $21.58 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  • [F9]This SAR was previously reported as a SAR relating to 23,708 shares of the Issuer's common stock at a base price of $21.39 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
Signature
/s/ John M. Winter, Attorney-in-Fact|2026-07-17

Documents

1 file
  • 4
    wk-form4_1784333637.xmlPrimary

    FORM 4